BRUKER CORP

Billerica, MA · Medtech · Public

High-performance scientific instruments for molecular and cellular analysis, including mass spectrometry, NMR, and microscopy systems for life science research and diagnostics

Claim this profile

Follows are private to you and power your alerts

Updated · bruker.com

Sector
Medtech
Headquarters
Billerica, MA
Latest Form D
$2M, Jan 2017
Total capital
$2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2M
1 Form D · last Jan 2017
118 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2017FEDERAL ↑EQUITY ↓Cumulative $2M1st Form D$2M
2017FEDERAL ↑EQUITY ↓Cumulative $2M1st Form D$2M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Anthony L. MattacchioneExecutive OfficerNamed in SEC Form D filings
  • Chris M. Van IngenDirectorNamed in SEC Form D filings
  • Cynthia M. FriendDirectorNamed in SEC Form D filings
  • Frank H. LaukienExecutive Officer, DirectorNamed in SEC Form D filings
  • Gilles G. MartinDirectorNamed in SEC Form D filings
  • Hermann A. RequardtDirectorNamed in SEC Form D filings
Show all 18 people
  • Joerg C. LaukienDirectorNamed in SEC Form D filings
  • John G. OrnellDirectorNamed in SEC Form D filings
  • Juergen R. SregaExecutive OfficerNamed in SEC Form D filings
  • Marc A. KastnerDirectorNamed in SEC Form D filings
  • Mark R. MunchExecutive OfficerNamed in SEC Form D filings
  • Michael G. KnellExecutive OfficerNamed in SEC Form D filings
  • Rene G. LenggenhagerExecutive OfficerNamed in SEC Form D filings
  • Richard D. KnissDirectorNamed in SEC Form D filings
  • Richard A. PackerDirectorNamed in SEC Form D filings
  • Robert A. RosenthalDirectorNamed in SEC Form D filings
  • Stephen W. FesikDirectorNamed in SEC Form D filings
  • William A. LintonDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Burl Concepts, Inc.Similar federal contract value in Medtech · null in contracts
  • EMRI SYSTEMS LLPSimilar federal contract value in Medtech · null in contracts
  • BIOMERICA INCSimilar federal contract value in Medtech · null in contracts
  • Immy Inc.Similar federal contract value in Medtech · null in contracts
  • Minimally Invasive Spinal Technology, LLCSimilar federal contract value in Medtech · null in contracts
  • TriAgenics, IncSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .